SLXN
Price
$8.30
Change
-$0.56 (-6.32%)
Updated
Aug 6, 04:51 PM (EDT)
Capitalization
5.13M
VANI
Price
$1.39
Change
-$0.11 (-7.33%)
Updated
Aug 6, 04:58 PM (EDT)
Capitalization
88.87M
13 days until earnings call
Interact to see
Advertisement

SLXN vs VANI

Header iconSLXN vs VANI Comparison
Open Charts SLXN vs VANIBanner chart's image
Silexion Therapeutics
Price$8.30
Change-$0.56 (-6.32%)
Volume$200
Capitalization5.13M
Vivani Medical
Price$1.39
Change-$0.11 (-7.33%)
Volume$500
Capitalization88.87M
SLXN vs VANI Comparison Chart in %
Loading...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SLXN vs. VANI commentary
Aug 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SLXN is a StrongBuy and VANI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 06, 2025
Stock price -- (SLXN: $8.86 vs. VANI: $1.50)
Brand notoriety: SLXN and VANI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SLXN: 38% vs. VANI: 936%
Market capitalization -- SLXN: $5.13M vs. VANI: $88.87M
SLXN [@Biotechnology] is valued at $5.13M. VANI’s [@Biotechnology] market capitalization is $88.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $215.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SLXN’s FA Score shows that 1 FA rating(s) are green whileVANI’s FA Score has 0 green FA rating(s).

  • SLXN’s FA Score: 1 green, 4 red.
  • VANI’s FA Score: 0 green, 5 red.
According to our system of comparison, VANI is a better buy in the long-term than SLXN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SLXN’s TA Score shows that 4 TA indicator(s) are bullish while VANI’s TA Score has 5 bullish TA indicator(s).

  • SLXN’s TA Score: 4 bullish, 5 bearish.
  • VANI’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, VANI is a better buy in the short-term than SLXN.

Price Growth

SLXN (@Biotechnology) experienced а -28.61% price change this week, while VANI (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.86%. For the same industry, the average monthly price growth was +14.59%, and the average quarterly price growth was +13.46%.

Reported Earning Dates

VANI is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (-0.86% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VANI($88.9M) has a higher market cap than SLXN($5.13M). VANI YTD gains are higher at: 29.310 vs. SLXN (-70.614). SLXN has higher annual earnings (EBITDA): -16.96M vs. VANI (-24.6M). SLXN has less debt than VANI: SLXN (3.48M) vs VANI (18.9M). SLXN (0) and VANI (0) have equivalent revenues.
SLXNVANISLXN / VANI
Capitalization5.13M88.9M6%
EBITDA-16.96M-24.6M69%
Gain YTD-70.61429.310-241%
P/E RatioN/AN/A-
Revenue00-
Total CashN/A13M-
Total Debt3.48M18.9M18%
FUNDAMENTALS RATINGS
VANI: Fundamental Ratings
VANI
OUTLOOK RATING
1..100
89
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SLXNVANI
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
8%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
20%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
31%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
42%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
51%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 10 days ago
51%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 6 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
44%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
59%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UFG2.940.14
+5.00%
Uni-Fuels Holdings Ltd
AMN17.490.06
+0.34%
AMN Healthcare Services
AMBO2.85N/A
-0.11%
Ambow Education Holding Ltd
AMCX5.98-0.03
-0.50%
AMC Networks
PATH11.22-0.12
-1.06%
UiPath

SLXN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLXN has been loosely correlated with IMA. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if SLXN jumps, then IMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLXN
1D Price
Change %
SLXN100%
-1.99%
IMA - SLXN
59%
Loosely correlated
-0.66%
CELC - SLXN
50%
Loosely correlated
-0.67%
MRSN - SLXN
43%
Loosely correlated
+2.62%
CHRS - SLXN
26%
Poorly correlated
+4.86%
QSI - SLXN
25%
Poorly correlated
N/A
More

VANI and

Correlation & Price change

A.I.dvisor indicates that over the last year, VANI has been loosely correlated with VTVT. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if VANI jumps, then VTVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VANI
1D Price
Change %
VANI100%
+7.14%
VTVT - VANI
60%
Loosely correlated
+0.99%
ADIL - VANI
37%
Loosely correlated
+4.48%
AXSM - VANI
36%
Loosely correlated
-2.77%
SCNI - VANI
34%
Loosely correlated
+5.96%
GLSI - VANI
34%
Loosely correlated
-1.84%
More